MPX Bioceutical Corporation

MPX Bioceutical Sales Rise 78% to $8 Million in Q4

MPX Bioceutical Corporation Reports Financial Results for Its Fiscal Year 2018 Company reports FY 2018 revenues of $21.3 million TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation...
- August 2nd, 2018 at 3:29 pm

MPX Postpones Filing Date of 2018 Annual Statements

Company to reschedule conference call with shareholders upon finalization of financial results TORONTO, July 30, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC:...
- July 30th, 2018 at 4:56 pm

MPX to Report Fiscal 2018 Earnings on Monday, July 30, 2018

TORONTO, July 26, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) today announced the Company will issue its fiscal 2018 full-year results release on July...
- July 26th, 2018 at 8:56 am

MPX Enters California Cannabis Extracts Market

MPX Enters Into Extraction Agreement With Southern California’s Largest Cannabis Processing Facility, Case Farms Collective Relationship will provide a full scale operation of services to MPX’s proprietary specifications and...
- July 19th, 2018 at 9:00 am

MPX to Open First Maryland Cannabis Dispensary

MPX Secures Final Approval to Open First Managed Dispensary in Maryland; Schedules Grand Opening for August 4th Production of MPX-branded cannabis to commence at managed facility as Company’s Maryland...
- July 17th, 2018 at 9:27 am

MPX Appoints Robert Petch to the Board of Directors

TORONTO, June 06, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that Robert Petch has joined the board of directors...
- June 6th, 2018 at 7:48 pm

MPX to Acquire Canadian LP Canveda for $18 Million

MPX Signs a Letter of Intent to Acquire Canadian Licenced Producer Canveda TORONTO, April 17, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to...
- April 17th, 2018 at 7:42 am

MPX Arizona Operations Post Record $4 Million Sales in March

Mpx Enjoys Record Monthly Revenue of Cdn$5.2 Million in Arizona TORONTO, April 03, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) has reported that its managed...
- April 3rd, 2018 at 7:49 am

MPX Bioceutical Reports FY18-Q3 Sales of $4.5 Million

MPX Reports Q3 Fiscal 2018 Results Execution of Expansion Strategy TORONTO, March 01, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Corporation” or “MPX”) (CSE:MPX) (OTCQB:MPXEF) reports financial results for its...
- March 1st, 2018 at 7:42 am

MPX Bioceutical Expands Maryland Medical Cannabis Operations

MPX Enters Into Management and Option Agreement With Dispensary in Baltimore, Maryland TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is...
- January 31st, 2018 at 5:31 pm

MPX Bioceutical Names David McLaren as New CFO

MPX Appoints New Chief Financial Officer TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) is pleased to announce the appointment of David McLaren...
- January 16th, 2018 at 7:55 am

MPX Expands Cannabis Operations in Maryland

MPX Enters Into Management and Option Agreements With Production Facility and Second Dispensary in Maryland One of only 14 Production Licenses Issued to Process Cannabis in the State of...
- January 8th, 2018 at 7:55 am